首页> Seminars in arthritis and rheumatism> Lower magnitude of humoral response to recombinant herpes zoster vaccine in immunocompromised Sjögren's disease patients: evidence from a randomized double-blinded placebo-controlled trial.

Lower magnitude of humoral response to recombinant herpes zoster vaccine in immunocompromised Sjögren's disease patients: evidence from a randomized double-blinded placebo-controlled trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sandra Gofinet,Pasoto

第一单位： Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

作者： Sandra Gofinet,Pasoto ^[1] ; Talita de Oliveira,Ribeiro ^[1] ; Nádia Emi,Aikawa ^[2] ; Ana Cristina,Medeiros-Ribeiro ^[1] ; Bruno da Silva,Borges ^[1] ; André Silva,Franco ^[1] ; Cássia Gisele Terrassani,Silveira ^[3] ; Henrique Carriço,da Silva ^[1] ; Eloisa,Bonfa ^[1] ; Clovis Artur Almeida,da Silva ^[4]

作者单位： Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. ^[1] Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Pediatric Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. ^[2] Immunology Laboratory, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. ^[3] Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Pediatric Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: clovis.silva@hc.fm.usp.br. ^[4]

关键词 Herpes zoster Immunogenicity Recombinant herpes zoster vaccine Safety Shingles Sj?gren's disease Sj?gren’s syndrome